Tools4Patient   Report issue

For profit Phase 2
Founded: Charleroi Belgium (2013)

Organization Overview

First Clinical Trial
2014
NCT02301169
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Tools4Patient

Active Ingredients

Drugs in Phase 2 Trials (1)

ipt803 (1 trial)

Drugs in Other Trials (2)

sodium chloride (2 trials)

t4p1001 (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Parkinson Disease (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 3